These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 1450435
1. Effect of vasopressin and V1 receptors blockade on hypotensive action of ANP in normotensive (WKY) and spontaneously hypertensive rats. Lapiński M, Stepniakowski K, Januszewicz A, Noszczyk B, Szczepańska-Sadowska E. J Physiol Pharmacol; 1992 Mar; 43(1):65-78. PubMed ID: 1450435 [Abstract] [Full Text] [Related]
2. Effects of vasopressin and V1 receptors blockade on blood pressure and heart rate in spontaneously hypertensive rats. Stepniakowski K, Lapiński M, Noszczyk B, Januszewicz A, Szczepańska-Sadowska E. Pol J Pharmacol Pharm; 1991 Mar; 43(6):487-93. PubMed ID: 1840331 [Abstract] [Full Text] [Related]
8. Pressor responsiveness to vasopressin in spontaneously hypertensive rats. Stepniakowski K, Lapiński M, Januszewicz A, Noszczyk B, Szczepańska-Sadowska E. Acta Physiol Pol; 1989 Mar; 40(2):171-82. PubMed ID: 2641416 [Abstract] [Full Text] [Related]
9. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats. Budzikowski A, Lon S, Paczwa P, Szczepanska-Sadowska E. J Auton Nerv Syst; 1992 Jun 15; 39(2):87-95. PubMed ID: 1430797 [Abstract] [Full Text] [Related]
13. [Effects of human atrial natriuretic factor-(99-126) on plasma and brain vasopressin in stroke-prone spontaneously hypertensive rats]. Sun SD, Zhang Q, Zhao XW, Tang J. Sheng Li Xue Bao; 1989 Feb 15; 41(1):56-62. PubMed ID: 2527409 [Abstract] [Full Text] [Related]
15. Effect of a chronic infusion of atrial natriuretic factor on glomerular and vascular receptors in spontaneously hypertensive rats. Cachofeiro V, Schiffrin EL, Thibault G, Cantin M, Garcia R. J Hypertens; 1989 Apr 15; 7(4):335-42. PubMed ID: 2542403 [Abstract] [Full Text] [Related]
16. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin. Abu-Amarah I, Balment RJ. Can J Physiol Pharmacol; 1999 Feb 15; 77(2):102-10. PubMed ID: 10535700 [Abstract] [Full Text] [Related]
17. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors. Yamauchi T, Ogura T, Oishi T, Harada K, Hashimoto M, Mimura Y, Asano N, Ota Z, Kageyama J. Acta Med Okayama; 1995 Feb 15; 49(1):53-9. PubMed ID: 7762410 [Abstract] [Full Text] [Related]
18. Central V1 AVP receptors are involved in cardiovascular adaptation to hypovolemia in WKY but not in SHR. Budzikowski AS, Paczwa P, Szczepańska-Sadowska E. Am J Physiol; 1996 Sep 15; 271(3 Pt 2):H1057-64. PubMed ID: 8853341 [Abstract] [Full Text] [Related]
19. Pretreatment with vasodilator or V1-antagonist abolishes vasopressin withdrawal hypotension in spontaneously hypertensive rats. Chiu EK, McNeill JR. J Hypertens; 1987 Oct 15; 5(5):593-8. PubMed ID: 2963065 [Abstract] [Full Text] [Related]
20. Modulation of the effect of endothelin-3 on blood pressure by atrial natriuretic peptide in conscious spontaneously hypertensive (SHR) and normotensive (WKY) rats. Januszewicz A, Stys A, Stys T, Lapinski M, Lon S. Blood Press; 1993 Jun 15; 2(2):146-54. PubMed ID: 8180728 [Abstract] [Full Text] [Related] Page: [Next] [New Search]